What is the recommended dosing for Acyclovir (antiviral medication) in adults with Herpes Simplex Virus (HSV) or Varicella-Zoster Virus (VZV) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosing for HSV and VZV Infections in Adults

The recommended dosing of acyclovir for adults with HSV or VZV infections varies by clinical presentation, with first episodes of genital herpes requiring 200 mg orally 5 times daily for 7-10 days, recurrent episodes requiring 200 mg orally 5 times daily for 5 days (or alternative regimens), and suppressive therapy requiring 400 mg orally twice daily for frequent recurrences. 1, 2, 3

Initial HSV Infections

First Clinical Episode of Genital Herpes

  • Standard regimen: Acyclovir 200 mg orally 5 times daily for 7-10 days or until clinical resolution 1
  • Alternative regimens:
    • Acyclovir 400 mg orally 3 times daily for 7-10 days 2, 3
    • Treatment should be continued until clinical healing is achieved 2

First Clinical Episode of Herpes Proctitis

  • Acyclovir 400 mg orally 5 times daily for 10 days or until clinical resolution 1

Recurrent HSV Episodes

Episodic Treatment

  • Start at first sign of prodrome or within 1-2 days of lesion onset 2
  • Recommended regimens:
    • Acyclovir 200 mg orally 5 times daily for 5 days 1
    • Acyclovir 400 mg orally 3 times daily for 5 days 1
    • Acyclovir 800 mg orally 2 times daily for 5 days 1, 2

Note: Starting treatment beyond 1-2 days after onset significantly reduces effectiveness by ≥50% 2

Suppressive Therapy

  • Indicated for: Patients with ≥6 recurrences per year 1, 2
  • Recommended regimen: Acyclovir 400 mg orally twice daily 1, 2
  • Alternative regimen: Acyclovir 200 mg orally 3-5 times daily 1, 2
  • Duration: Up to 12 months, followed by reassessment 3
  • After 1 year of continuous suppressive therapy, discontinue to assess recurrence rate 1, 2

Varicella-Zoster Virus (VZV) Infections

Herpes Zoster (Shingles)

  • Recommended regimen: Acyclovir 800 mg orally 5 times daily for 7-10 days 2, 3, 4
  • Treatment should be initiated as soon as possible after symptom onset 2

Chickenpox

  • Adults: Acyclovir 800 mg orally 4 times daily for 5 days 3
  • Treatment should be initiated at the earliest sign or symptom 3

Severe Disease Requiring Hospitalization

Severe HSV or Disseminated Infection

  • Recommended regimen: Acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical resolution 1, 5

Severe VZV Infection in Immunocompromised Patients

  • Acyclovir 500 mg/m² IV every 8 hours for 7 days 5

Dosage Adjustment for Renal Impairment

Oral Acyclovir

Creatinine Clearance 200 mg Regimen 400 mg Regimen 800 mg Regimen
>10 mL/min/1.73m² 200 mg every 4 hours 400 mg every 12 hours 800 mg every 4 hours
0-10 mL/min/1.73m² 200 mg every 12 hours 200 mg every 12 hours 800 mg every 12 hours

IV Acyclovir

  • Dosage adjustment is necessary based on creatinine clearance 5
  • Adequate hydration during treatment is essential to minimize nephrotoxicity risk 2

Important Clinical Considerations

  • Acyclovir neither eradicates latent virus nor affects subsequent risk after discontinuation 1, 2
  • Suppressive therapy reduces but does not eliminate asymptomatic viral shedding 2
  • Immunocompromised patients may require higher doses and longer treatment courses 2
  • Patients should be advised to abstain from sexual activity while lesions are present 1
  • Topical acyclovir therapy is substantially less effective than oral therapy and is not recommended 1
  • For acyclovir-resistant HSV (primarily in immunocompromised patients), foscarnet 40 mg/kg IV three times daily or 60 mg/kg IV twice daily is recommended 1, 6
  • Monitor for neurological symptoms that may indicate acyclovir neurotoxicity, especially in patients with renal impairment 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cold Sore Recurrences

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Therapy of herpes zoster with oral acyclovir.

The American journal of medicine, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.